Once again, another working week is coming to a close. And as you know, this is our treasured signal to daydream about weekend plans. Our agenda is modest, as always, but filled with activities. These include an exciting scavenger hunt, unexciting yard work, hanging with the short people and taking a constitutional or two. What about you? This is a marvelous time to enjoy the great outdoors. Or you can catch up with a special someone. Or simply make plans for that needed summer vacation. Whatever you do, have a grand time, but be safe. See you soon...
US House To Vote On Track-And-Trace Bill Next Week (The Hill)
Sun Pharma In Talks To Buy Sweden's Meda (Times of India)
FDA Tells PharmAthene To Proceed with Anthrax Vaccine Trial (Associated Press)
Three More Coronavirus Deaths In Saudi Arabia (Reuters)
Stop-Smoking Therapies Raise Quitting Odds (MedPage Today)
Japan Launches $100M Plan For Drugs For Poor Nations (Pharma Times)
EU Backs Celgene And Aegerion Drugs (Reuters)
Biogen Delays Launch Of MS Pill In Europe (Bloomberg News)
FDA Rejects Endo Testosterone Drug, Again (Reuters)
BioMarin Gets FDA Priority Review For Rare Disease Drug (Pharma Times)
EU Calls For Curbs On Glaxo And Valeant Epilepsy Drug (Reuters)
Satori Pharma Closes After Alzheimer's Drug Fails (Fierce Biotech)
Some Common Prescriptions Are Linked To Impotence (Reuters)
EDITOR'S NOTE: Please check this post for additional stories during the day
1 Comment
Definitely flawed ED study, with selection bias. Ask any guy who takes a beta blocker for hypertension when was the last time he had an erection he will be scratching his head on that one. When I was a lad in grad school virtually all of the AHT's, especially the rauwolfia alkaloids caused impotence if they didn't kill you first.